Abstract:Background: Basal ganglia and thalamic arteriovenous malformations (AVMs) represent a special subset of malformations. Due to the involvement of vital brain structures and the specifically fine and delicate angioarchitecture of these lesions, it presents unique therapeutic challenges and technical difficulties that require thorough treatment planning, individualized treatment strategies, and advanced techniques for good clinical outcome. Method: In this study, we presented a series of ruptured basal ganglia and thalamic AVMs embolized via a transarterial, transvenous or combined approach. Herein, we summarized our treatment experience and clinical outcomes to further evaluate the effectiveness and safety of endovascular embolization for these AVMs as well as the indications, therapy strategies, and techniques of embolization procedures. Results: Twelve patients with basal ganglia and thalamus AVMs were included in the study. Their average age was 23.83 ± 16.51 years (range, 4–57 years) with a female predominance of 67% at presentation. The AVMs were located in the thalamus in 3 (25%) patients, in the basal ganglia in 3 (25%) patients, and in both sites of the brain in 6 (50%) patients. There were 5 AVMs located on the left side and 7 on the right. The mean nidus diameter was 3.32 ± 1.43 cm (range 1.3–6.1 cm). According to the Spetzler-Martin grading classification, 4 (33.3%) brain AVMs were Grade III, 7 (58.3%) were Grade IV, and 1 (8.3%) was Grade V. All of them presented with bleeding at admission: four of these patients presented with an intracerebral hemorrhage (ICH), 8 ICH in combination with intraventricular hemorrhage (IVH), and no patient with subarachnoid hemorrhage (SAH). Among these patients treated with endovascular embolization, 7 patients were treated by the transarterial approach, 4 patients transvenous approach, and 1 patient underwent the combined approach. A single embolization procedure was performed in 6 patients (50%) and the other 6 cases (50%) were treated in a staged manner with up to three procedures. Procedure-related complications occurred only in two patient (16.7%). Complete AVM obliteration was obtained in 7 patients (58.3%), and partial obliteration was in 4 patients (33.3%). Overall, good or excellent outcomes were obtained in 7 patients (58.3%), and poor functional outcome was observed in 5 patients (41.7%) at the last follow-up. All survived patients achieved anatomic stabilization and there was no postoperative bleeding or recurrence in the follow-up. Conclusion: The management of the basal ganglia and thalamic AVMs is a great challenge, which needs multimodal individualized treatment to improve the chances of radiographic cure and good outcomes. Endovascular therapy is safe and effective in the treatment of cerebral AVMs particularly for deep-seated AVMs such as the basal ganglia and thalamus. Our results demonstrate a high rate of anatomic obliteration with an acceptable rate of complications in the endovascular treatment of these vasculopathies via a transarterial approach or a transvenous approach.

Complications Caused by Cerebral Arteriovenous Malformation Embolization

Relationship of Bleeding Complications and Impairment of Draining Veins after Α-N-butyl Cyanoacrylate Embolization of Brain Arteriovenous Malformations

Brain AVM Embolization with Onyx and Post-Embolic Management

Microsurgical Excision Combined with Preoperational Endovascular Embolization in Treatment of Cerebral Arteriovenous Malformation

Endovascular embolization for basal ganglia and thalamic arteriovenous malformations

Endovascular Treatment Accounts for a Change in Brain Arteriovenous Malformation Natural History Risk

A Clinical Study of the Treatment of Cerebral Arteriovenous Malformations with Endovascular Embolization

Endovascular Treatment of Cerebellar Arteriovenous Malformations: A Single-Center Experience of 75 Consecutive Patients

Cerebral Arteriovenousmalformation Embolization Prevention of Postoperative Complications

Endovascular Embolization Combined with Microsurgery in Treatment of Cerebral Arteriovenous Malformations(a report of 23 cases)

[Endovascular Embolization of Cerebral Arteriovenous Malformation].

Clinical efficacy of transvenous curative embolization of intracranial arteriovenous malformations: a preliminary observation

Transvenous embolization of brain arteriovenous malformations: a review of techniques, indications, and outcomes.

Effect of endovascular embolization combined with two-stage stereotacticradiosurgery for the treatment of intracranial arteriovenous malformation

Endovascular transvenous treatment for superficial intracranial arteriovenous malformations

Single-center experience of transvenous embolization of superficial intracranial arteriovenous malformations

Recurrence of Cerebral Arteriovenous Malformation Following Complete Obliteration Through Endovascular Embolization

Efficacy and safety of embolization for arteriovenous malformations of the basal ganglia and thalamus via the transarterial approach

Spontaneous Thrombosis in Main Draining Veins of Unruptured Cerebral Arteriovenous Malformations

Intramedullary Arteriovenous Malformations: Vascular Architecture and Endovascular Embolization

Transvenous embolization of brain arteriovenous malformations: a systematic review and meta-analysis.